Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Par Pharmaceutical Companies, a developer of generic drugs and innovative branded pharmaceuticals, has announced the resignation of Gerard Martino, the company's executive vice president and COO.
Subscribe to our email newsletter
Par has earlier announced a resizing of its generic business as part of an ongoing strategic assessment of the overall business. Mr Martino will stay on through the transition.
Patrick LePore, chairman, CEO and president of Par, said: “All of us at Par are grateful to Jerry for the many contributions he has made to the company. Jerry led us through a very difficult time during our financial restatement and engineered significant improvement to Par’s systems, operations and business practices. We wish him success in his future endeavors.”